Hip Muscle Strength in FAI Versus Normal Controls

Muscle Strength in Femoroacetabular Impingement: A Comparative Study of Patients With FAI Versus Normal Controls

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02697097

Enrollment

Registered

2016-03-03

Start date

2016-04-30

Completion date

2017-08-31

Last updated

2016-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoro-acetabular Impingement

Keywords

Hip Muscle Strength, FAI

Brief summary

Hip Muscle Strength in femoro-acetabular impingement participants versus normal controls. To investigate the hip muscle strength in a normal control group and compare this to patients who have a diagnosis of femoro-acetabular impingement (diagnosed clinically and with confirmed radiological features).

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 30 Years

Healthy volunteers

Yes

Inclusion criteria

* Males and Females. * Aged 18-30. * Control group - Normal range of movement and no evidence of femoro-acetabular impingement on clinical examination (negative impingement test, no symptoms). * Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).

Exclusion criteria

* Patients under the age of 18. * Patients over the age of 30. * Control group - evidence of underlying pathology affecting the hip, abnormal range of motion, evidence of femoro-acetabular impingement on clinical examination. * Previous surgery of the hip joints. * Medical history of arthritis (including rheumatoid and reactive). * Family history of femoro-acetabular impingement (control arm participants). * Patients who are currently experiencing or have experienced hip pain in the previous 1 year (control arm). * Other conditions (e.g. neurological, muscular dystrophy etc) which may affect hip muscle strength.

Design outcomes

Primary

Measure	Time frame
Muscle Strength on Dynamometer	3 months

Secondary

Measure	Time frame
Kinematics of the Hip - Range of Movement	3 months

Countries

United Kingdom

Contacts

Primary ContactVikas Khanduja, MA, FRCS (Orth)

vk279@cam.ac.uk01223 257093

Backup ContactArman Memarzadeh, MRCS

a.memarzadeh@doctors.org.uk+447985430103

Outcome results